Marshall Wace’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-228,642
| Closed | -$725K | – | 1804 |
|
|
2023
Q3 | $725K | Buy |
228,642
+185,296
| +427% | +$587K | ﹤0.01% | 1343 |
|
|
2023
Q2 | $215K | Sell |
43,346
-391,674
| -90% | -$1.95M | ﹤0.01% | 1804 |
|
|
2023
Q1 | $2.15M | Buy |
+435,020
| New | +$2.15M | ﹤0.01% | 1140 |
|
|
2022
Q4 | – | Sell |
-12,593
| Closed | -$136K | – | 2291 |
|
|
2022
Q3 | $136K | Buy |
+12,593
| New | +$136K | ﹤0.01% | 2388 |
|
|
2022
Q1 | – | Sell |
-948,624
| Closed | -$14.2M | – | 2572 |
|
|
2021
Q4 | $14.2M | Buy |
+948,624
| New | +$14.2M | 0.03% | 590 |
|
|
2021
Q3 | – | Sell |
-456,591
| Closed | -$11.9M | – | 2355 |
|
|
2021
Q2 | $11.9M | Buy |
+456,591
| New | +$11.9M | 0.05% | 353 |
|
|
2020
Q2 | – | Sell |
-132,006
| Closed | -$2.57M | – | 1479 |
|
|
2020
Q1 | $2.57M | Sell |
132,006
-21,099
| -14% | -$410K | 0.03% | 540 |
|
|
2019
Q4 | $3.98M | Buy |
+153,105
| New | +$3.98M | 0.03% | 570 |
|
|
2019
Q3 | – | Sell |
-19,524
| Closed | -$525K | – | 1605 |
|
|
2019
Q2 | $525K | Sell |
19,524
-42,118
| -68% | -$1.13M | ﹤0.01% | 1042 |
|
|
2019
Q1 | $1.78M | Buy |
+61,642
| New | +$1.78M | 0.02% | 770 |
|